Ocular Therapeutix (OCUL) Free Cash Flow (2017 - 2026)
Ocular Therapeutix (OCUL) free cash flow from Jun 30, 2017 to Mar 31, 2026. The TTM Ocular Therapeutix (OCUL) free cash flow is -$241M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Ocular Therapeutix (OCUL) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +62.34% |
| 3 Years TTM | +52.60% |
| 5 Years TTM | +35.46% |
| All Time TTM | +25.26% |
Annual Free Cash Flow change of Ocular Therapeutix (OCUL)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$71M | -67.43% |
| 2025 | -$217M | +59.51% |
| 2024 | -$136M | +78.16% |
| 2023 | -$76M | +20.53% |
| 2022 | -$63M | -5.12% |
| 2021 | -$67M | +22.71% |
| 2020 | -$54M | -31.86% |
| 2019 | -$80M | +56.14% |
| 2018 | -$51M | -12.94% |
| 2017 | -$59M | N/A |
Comparison Ocular Therapeutix (OCUL) five years free cash flow CAGR with competitors
Ocular Therapeutix (OCUL) five years free cash flow CAGR is 35.47%.